Target intelligence / Profile preview

Epididymal protease inhibitor (EPPIN)

Target
EPPIN
Molecular classification
Protease inhibitor, Serine protease inhibitor, WFDC (Whey-acidic protein four-disulfide core) family, Kunitz domain-containing protein, Secreted protein
01

Overview

Epididymal protease inhibitor (EPPIN) is a secreted, cysteine-rich protein found on the surface of human sperm, encoded by the SPINLW1 gene on chromosome 20q12-13.2[2][3][6]. EPPIN contains both a Kunitz-type and a WAP (whey acidic protein) four-disulfide core (WFDC) domain and is part of a gene family implicated in protease inhibition and host defense[1][3][6]. During ejaculation, EPPIN binds semenogelin-1 (SEMG1), temporarily inhibiting sperm motility; subsequent cleavage of SEMG1 by prostate-specific antigen (PSA/KLK3) restores sperm motility in the female tract[1][2][6]. EPPIN is essential for male fertility, as its disruption by anti-EPPIN antibodies or small molecules (such as EP012 and EP055) impairs sperm motility and provides reversible male contraception in preclinical models[1][2]. EPPIN also provides antimicrobial protection to sperm in the ejaculate and is under investigation both as a therapeutic contraceptive target and as a gene implicated in some infertility cases[2][6][1].

Other names
EppinSPINLW1WAP7WFDC7CT71Epididymal peptidase inhibitorCancer/testis antigen 71Cancer/testis antigen 72Protease inhibitor WAP7Serine peptidase inhibitor-like with Kunitz and WAP domains 1WAP four-disulfide core domain protein 7Epididymis secretory sperm binding proteindJ461P17.2
02

Mechanism of action

Inhibition of EPPIN-SEMG1 binding (and thus sperm motility); Spermiostatic effect via modulation of sperm surface protein interactions

03

Biological functions

Sperm motility regulationModulation of protease (PSA/KLK3) activitySperm antimicrobial protectionSperm surface protein-protein interactionMale fertility maintenance
04

Disease associations

Male infertilityContraception (target for male non-hormonal contraceptive development)Other (potentially as a cancer/testis antigen)
05

Safety considerations

Need for reversible targeting to avoid permanent infertilityLimited off-target expression, but full tissue distribution and immunogenicity remain to be characterized
06

Interacting drugs

EP012

2 more in the full profile.

07

Biomarkers

Anti-EPPIN antibody titers (experimental marker for contraceptive efficacy in animal studies)EPPIN expression/presence on sperm surface (research marker in infertility)

Beyond the preview

Go deeper on Epididymal protease inhibitor (EPPIN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Epididymal protease inhibitor (EPPIN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call